| Abstrakt: |
A new report discusses research findings on aortic valve stenosis, specifically focusing on low-risk patients with symptomatic severe bicuspid aortic valve stenosis. The study evaluated the feasibility and outcomes of transcatheter aortic valve replacement (TAVR) in this patient population. The analysis included 72 low-risk patients who underwent TAVR, with a 2-year follow-up showing a mortality rate of 1.5% and commendable clinical outcomes. The study concludes that TAVR is safe and effective for patients with bicuspid aortic stenosis. [Extracted from the article] |
